The mitochondrial protectant dexpramipexole (DPX) could sustain mitochondrial function and inhibit NLRP3/caspase-1 pyroptosis pathway, thus ameliorating neuroinflammation and cognitive impairment in SAE (Zhang et al., 2023). This evidence concerns the gene NLRP3 and Cognitive impairment.